FDA approves generic version of Jazz Pharma's sleep disorder drug

(Reuters) - The U.S. Food and Drug Administration said it had approved the first generic version of Xyrem, Jazz Pharmaceuticals Plc's drug to treat patients with narcolepsy, a kind of sleeping disorder.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news